Jaymie Sawyer, PhD
Dr Sawyer’s career, beginning with her PhD in Genetics from the University of Wisconsin, has focused on antibody engineering and immunoassay development, particularly via new technologies and automation. After completing a fellowship in the Laboratory of Tumor Immunology at NCI, improving soluble expression of anti-tumor antibody fragments in E.coli, Dr Sawyer took a role in Antibody Engineering at Boehringer Mannheim Diagnostics. There, she trained in phage display and carried out projects in the labs of Jim Marks (UCSF) and Greg Winter (MRC). As a founding member of Motorola Biochip systems, Dr Sawyer was responsible for the inception and development of protein arrays on the Codelink platform as well as developing applications for microfluidics and label-less detection technologies. She later moved to BD Biosciences, where as Director of Reagent and Assay Development, she set up a high throughput screening lab for phage libraries in collaboration with Dyax Corp. identifying and commercializing affinity reagents for use in Immunology research. Along with immunogen and antibody development, she was also responsible for the Cytometric Bead Assay bringing multiplexed immuno-assays to market. Dr Sawyer then moved on to SQI Diagnostics, where, as VP of R&D she led development of fully automated, dual-level multiplex protein microarrays for quantitation of isotype responses to multiple antigens in a single well. Along with gaining regulatory approvals for autoimmune diagnostics, she extended the platform to address high value bioanalytics (ADA and PK) for drug development. After consulting on new technology assessment for Illumina Ventures, Dr Sawyer took a role as VP of Product Develop at Serimmune, whose platform applies bacterial display peptide libraries, next generation sequencing and custom bioinformatics to gain a broad view of immune repertoires. Dr Sawyer continues to consult, relying on her deep reagent and assay development expertise.